Johnson & Johnson (JNJ)
146.52
-2.01
(-1.35%)
USD |
NYSE |
Apr 25, 12:10
Johnson & Johnson Cash from Investing (Quarterly): -1.202B for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.202B |
| September 30, 2023 | 2.541B |
| June 30, 2023 | -3.776B |
| March 31, 2023 | 3.315B |
| December 31, 2022 | -4.397B |
| September 30, 2022 | -1.701B |
| June 30, 2022 | -2.639B |
| March 31, 2022 | -3.634B |
| December 31, 2021 | -5.36B |
| September 30, 2021 | -2.719B |
| June 30, 2021 | -419.00M |
| March 31, 2021 | -185.00M |
| December 31, 2020 | -7.903B |
| September 30, 2020 | -4.819B |
| June 30, 2020 | -7.522B |
| March 31, 2020 | -581.00M |
| December 31, 2019 | -1.344B |
| September 30, 2019 | -1.645B |
| June 30, 2019 | -1.788B |
| March 31, 2019 | -1.417B |
| December 31, 2018 | 2.228B |
| September 30, 2018 | -4.269B |
| June 30, 2018 | -201.00M |
| March 31, 2018 | -925.00M |
| December 31, 2017 | -505.00M |
| Date | Value |
|---|---|
| September 30, 2017 | -1.18B |
| June 30, 2017 | -12.25B |
| March 31, 2017 | -936.00M |
| December 31, 2016 | -2.174B |
| September 30, 2016 | -2.372B |
| June 30, 2016 | 1.322B |
| March 31, 2016 | -1.537B |
| December 31, 2015 | -1.391B |
| September 30, 2015 | -1.001B |
| June 30, 2015 | -3.554B |
| March 31, 2015 | -1.789B |
| December 31, 2014 | -2.922B |
| September 30, 2014 | 735.00M |
| June 30, 2014 | -8.092B |
| March 31, 2014 | -2.026B |
| December 31, 2013 | -1.578B |
| September 30, 2013 | -1.553B |
| June 30, 2013 | -569.00M |
| March 31, 2013 | -1.403B |
| December 31, 2012 | -2.503B |
| September 30, 2012 | -1.937B |
| June 30, 2012 | -4.126B |
| March 31, 2012 | 4.056B |
| December 31, 2011 | 6.238B |
| September 30, 2011 | -1.59B |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-7.903B
Minimum
Dec 2020
3.315B
Maximum
Mar 2023
-2.409B
Average
-1.788B
Median
Jun 2019
Cash from Investing (Quarterly) Benchmarks
| Amgen Inc | -27.09B |
| Gilead Sciences Inc | -727.00M |
| Eli Lilly and Co | -2.924B |
| Merck & Co Inc | 53.00M |
| Shockwave Medical Inc | -242.26M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 7.863B |
| Cash from Financing (Quarterly) | -4.655B |
| Free Cash Flow | 17.78B |
| Free Cash Flow Per Share (Quarterly) | 2.387 |
| Free Cash Flow to Equity (Quarterly) | 6.393B |
| Free Cash Flow to Firm (Quarterly) | 5.804B |
| Free Cash Flow Yield | 4.84% |